After a labeling mix-up prompted a recall of a popular panic disorder drug this summer, Endo’s U.S. subsidiary is widening the scope of its product pull. | Endo USA is expanding its previous recall of ...
As BeiGene works to change its corporate identity and grow the reach of its cancer offerings around the globe, the company ...
Neurology patient groups have chided the pharma industry for investing too little into treating disorders of the nervous ...
On the heels of the premiere of its first-ever Spanish-language Cologuard campaign, Exact Sciences is doubling down on its ...
Ideaya Biosciences has made a key hire in anticipation of the launch of its first drug, securing the services of an executive ...
On Tuesday, company revealed that its subcutaneous formulation of Keytruda has aced a phase 3 trial, demonstrating ...
Cardiometabolic disease biotech NeuroBo Pharmaceuticals is shaking up its corporate image with a complete rebrand. | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback